Review: The JAK/STAT Protein Activation – Role in Cancer Development and Targeted Therapy

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Current Signal Transduction Therapy

• Publication date

  2012-08-31

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.2174/157436212802481619
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• Recent advances and future perspectives in small molecule JAK2 inhibitors.

  2025cites this paper
• Tyk2 is a tumor suppressor in colorectal cancer

  2022cites this paper
• Self-renewal signaling pathways in breast cancer stem cells.

  2019cites this paper
• Hesperidin promotes programmed cell death by downregulation of nongenomic estrogen receptor signalling pathway in endometrial cancer cells.

  2018cites this paper
• Sarcodon imbricatus polysaccharides improve mouse hematopoietic function after cyclophosphamide-induced damage via G-CSF mediated JAK2/STAT3 pathway

  2018cites this paper
• Structural Biology of STAT3 and Its Implications for Anticancer Therapies Development

  2018cites this paper
• Molecular docking, 3D-QSAR, molecular dynamics, synthesis and anticancer activity of tyrosine kinase 2 (TYK 2) inhibitors

  2018cites this paper
• Changes of signal transductivity and robustness of gene regulatory network in the carcinogenesis of leukemic subtypes via microarray sample data

  2018cites this paper
• LncRNA AB073614 induces epithelial- mesenchymal transition of colorectal cancer cells via regulating the JAK/STAT3 pathway

  2018cites this paper
• ATM Is Required for the Prolactin-Induced HSP90-Mediated Increase in Cellular Viability and Clonogenic Growth After DNA Damage

  2018cites this paper
• Chapter 10 – Big Evolutionary Mechanisms of Network Robustness and Signaling Transductivity in Aging and Carcinogenic Process by System Modeling and Database Mining

  2017cites this paper
• Molecular modeling-driven approach for identification of Janus kinase 1 inhibitors through 3D-QSAR, docking and molecular dynamics simulations

  2017cites this paper
• Promoter methylation and expression of SOCS-1 affect clinical outcome and epithelial-mesenchymal transition in colorectal cancer.

  2016cites this paper
• The Synthesis and Optimization of Bioactive Natural Products as Anticancer and Antileishmanial Agents

  2015cites this paper
• Scaffold hopping towards potent and selective JAK3 inhibitors: discovery of novel C-5 substituted pyrrolopyrazines.

  2014cites this paper
• Novel triazolo-pyrrolopyridines as inhibitors of Janus kinase 1.

  2013cites this paper
• Interrogation of EpoR Fidelity in Myelodysplastic Syndrome Hematopoiesis and Stabilization by the Immunomodulatory Agent, Lenalidomide

  2013influential citation